Parallel Advisors’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.4M Sell
56,244
-2,325
-4% -$182K 0.09% 166
2025
Q1
$4.24M Sell
58,569
-7,229
-11% -$524K 0.1% 161
2024
Q4
$4.87M Sell
65,798
-3,476
-5% -$257K 0.11% 145
2024
Q3
$4.57M Buy
69,274
+3,119
+5% +$206K 0.11% 144
2024
Q2
$6.11M Buy
66,155
+2,756
+4% +$255K 0.16% 114
2024
Q1
$6.06M Buy
63,399
+6,647
+12% +$635K 0.16% 108
2023
Q4
$4.33M Sell
56,752
-1,442
-2% -$110K 0.13% 123
2023
Q3
$4.03M Sell
58,194
-301
-0.5% -$20.9K 0.13% 130
2023
Q2
$5.52M Buy
58,495
+892
+2% +$84.1K 0.18% 107
2023
Q1
$4.77M Buy
57,603
+52,443
+1,016% +$4.34M 0.16% 117
2022
Q4
$385K Sell
5,160
-1,312
-20% -$97.9K 0.02% 484
2022
Q3
$535K Sell
6,472
-1,324
-17% -$109K 0.02% 373
2022
Q2
$741K Buy
7,796
+313
+4% +$29.8K 0.03% 293
2022
Q1
$876K Sell
7,483
-725
-9% -$84.9K 0.03% 297
2021
Q4
$1.06M Buy
8,208
+541
+7% +$70.1K 0.04% 259
2021
Q3
$868K Buy
7,667
+3,256
+74% +$369K 0.04% 281
2021
Q2
$457K Buy
4,411
+874
+25% +$90.6K 0.02% 408
2021
Q1
$296K Buy
3,537
+274
+8% +$22.9K 0.01% 501
2020
Q4
$298K Sell
3,263
-633
-16% -$57.8K 0.02% 461
2020
Q3
$311K Buy
3,896
+178
+5% +$14.2K 0.02% 412
2020
Q2
$256K Buy
3,718
+70
+2% +$4.82K 0.02% 462
2020
Q1
$229K Buy
3,648
+612
+20% +$38.4K 0.02% 406
2019
Q4
$236K Buy
3,036
+51
+2% +$3.96K 0.02% 450
2019
Q3
$219K Buy
2,985
+1,587
+114% +$116K 0.02% 434
2019
Q2
$86K Sell
1,398
-21
-1% -$1.29K 0.01% 697
2019
Q1
$90K Sell
1,419
-633
-31% -$40.1K 0.01% 636
2018
Q4
$101K Buy
2,052
+207
+11% +$10.2K 0.01% 533
2018
Q3
$99K Buy
1,845
+600
+48% +$32.2K 0.01% 606
2018
Q2
$60K Buy
1,245
+288
+30% +$13.9K 0.01% 676
2018
Q1
$45K Buy
957
+9
+0.9% +$423 0.01% 725
2017
Q4
$36K Buy
948
+348
+58% +$13.2K 0.01% 803
2017
Q3
$21K Sell
600
-9
-1% -$315 ﹤0.01% 983
2017
Q2
$23K Sell
609
-3
-0.5% -$113 ﹤0.01% 954
2017
Q1
$22K Buy
612
+174
+40% +$6.26K ﹤0.01% 925
2016
Q4
$14K Buy
+438
New +$14K ﹤0.01% 988